EcoDrugPlus

Solute Carrier Family 6 Member 2

Ensembl ID : ENSDNOG00000035160
Gene Symbol: SLC6A2
4 Cross references
204 Possible Orthologues:

Solute Carrier Family 6 Member 4

Ensembl ID : ENSDNOG00000001931
Gene Symbol: SLC6A4
2 Cross references
205 Possible Orthologues:

Solute Carrier Family 6 Member 9

Ensembl ID : ENSDNOG00000037887
Gene Symbol: SLC6A9
2 Cross references
207 Possible Orthologues:

Solute Carrier Family 9 Member A3

Ensembl ID : ENSDNOG00000011710
Gene Symbol: SLC9A3
2 Cross references
238 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSDNOG00000000662
Gene Symbol: SSTR1
4 Cross references
160 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSDNOG00000041650
Gene Symbol: SSTR2
4 Cross references
264 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSDNOG00000042020
Gene Symbol: SSTR3
4 Cross references
251 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSDNOG00000038307
Gene Symbol: SSTR4
4 Cross references
102 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSDNOG00000042445
Gene Symbol: SSTR5
4 Cross references
257 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSDNOG00000041311
Gene Symbol: SPHK2
4 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSDNOG00000033684
Gene Symbol: S1PR1
3 Cross references
193 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSDNOG00000042290
Gene Symbol: SYK
2 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).